Himalaya Nutravedics India IPO
Himalaya Nutravedics India LtdSME
This IPO closed on 24 Sep 2026.
- Open date
- 22 Sep 2026
- Close date
- 24 Sep 2026
- Min. Investment
- ₹2,54,400
- Lot Size
- -
- Fresh Issue
- ₹26.50 Cr
- Price Range
- -
- Face Value
- -
- IPO Document
- DRHP - PDF(opens in a new tab)
Subscription rate
- Qualified Institutional Buyers1.00x
- Non-Institutional Investors2.90x
- Retail-Individual Investors2.56x
- Total2.24x
Schedule
- Completed: IPO open date22 Sep 2026
- Completed: IPO close date24 Sep 2026
- Completed: Allotment date25 Sep 2026
- Completed: Funds unblock or debit28 Sep 2026
- Current step: Tentative listing date29 Sep 2026
About
Promoter shareholding in Himalaya Nutravedics India Ltd, before and after the issue.
| Promoter | Pre-issue shares | Pre-issue % | Post-issue shares | Post-issue % |
|---|---|---|---|---|
| Rohit Asawa | 2,97,000 | 4.71% | 2,97,000 | 3.37% |
| Divya Asawa | 15,33,000 | 24.31% | 15,33,000 | 17.41% |
| Chanda Asawa | 27,22,500 | 43.17% | 27,22,500 | 30.92% |
| Rama Raju Penmatsa | 9,60,000 | 15.22% | 9,60,000 | 10.90% |
| Swathi Penmatsa | 4,80,000 | 7.61% | 4,80,000 | 5.45% |
| Shilpa Attal | 7,500 | 0.12% | 7,500 | 0.09% |
Himalaya Nutravedics India IPO Strengths & Risks
- Experienced Promoters and Management Team.
- End to end execution capabilities.
- Long term Relationship with the Clients.
- Quality Assurance & Control.
- Risks Relating to the Business: The company may be unable to sufficiently obtain, maintain, protect, or enforce its intellectual property and other proprietary rights.
- Risks Relating to the Business: The company derives a significant portion of its revenue from the sale of products in the Ayurvedic products which constituted 94.57%, 92.09% and 79.27% of the company's revenue from operations for the Fiscals 2026, 2025 and 2024, respectively. Any reduction in demand for these products could have an adverse effect on its business, results of operations, financial condition and cash flows.
- Risks Relating to the Business: The company is dependent on and derives a substantial portion of its revenue from certain key customers. Revenue generated from the company's top 10 customers accounted for 81.24%, 86.97%, and 84.19%, of its revenue from operations during the Fiscals 2026, 2025 and 2024, respectively. Loss of relationship with any of these customers or delays or reductions in their orders may have an adverse effect on the company's business, results of operations, financial condition and cash flows.
- Risks Relating to the Business: The company has historically derived, and may continue to derives, a significant portion of its supply from top 10 Suppliers.
- Risks Relating to the Business: The company profitability may be adversely affected upon the expiry of tax benefits available under Section 80-IAC of the Income Tax Act, 1961, as applicable under the existing tax regime, and under Section 140 of the Income Tax Act, 2025, upon such new tax regime becoming effective.
- Risks Relating to the Business: The company operates out of a single Manufacturing Facility, located at Hyderabad, Telangana which exposes its operations to potential geographical concentration risks arising from local and regional factors which may adversely affect the company operations and in turn its business, results of operations and cash flows.
- Risks Relating to the Business: The Company is significantly dependent on the experience, expertise, and continued support of its Promoters for the growth and development of the company's business, and any loss of their involvement could adversely affect its operations and future prospects.
- Risks Relating to the Business: The company's Registered and Corporate Office and Factory is located on the same premise, which is not owned by the company and has been taken on a long term lease. Disruption of its rights as lessee or termination of the agreement with the company's lessor may adversely impact its operations and, consequently, the company's business, financial condition and results of operations.
- Risks Relating to the Business: The company's inability to accurately forecast demand for its products and manage the company's inventory may have an adverse effect on its business, results of operations, financial condition and cash flows.
- Risks Relating to the Business: The company's business is subject to stringent and evolving labelling and regulatory requirements under applicable laws, including those administered by the Food Safety and Standards Authority of India and the Ministry of AYUSH, and any failures to comply may adversely affect the company's business.
- Risks Relating to the Business: There are certain discrepancies/errors/delayed-filings which have occurred in some of the company's corporate secretarial records relating to forms filed with the RoC under the provisions of the Companies Act, 2013.
- Risks Relating to the Business: Products returned by Stockists upon expiry may adversely affect the company's revenue, margins and inventory management.
- Risks Relating to the Business: The company does not have long-term contracts with its suppliers and customers, which may expose the company to risks relating to supply disruptions and loss of business.
- Risks Relating to the Business: The company has had negative cash flows from operating activities in the past and may, in the future, experience similar negative cash flows.
- Risks Relating to the Business: Any delay in payment of statutory dues by the Company in future, may result in the imposition of penalties and in turn may have an adverse effect on the Company's business, financial condition, results of operation and cash flows.
- Risks Relating to the Business: The Company may incur losses in the future, which could adversely affect its business, financial condition and results of operations.
- Risks Relating to the Business: The company's inability to effectively implement and scale its digital and online initiatives may adversely affect the company's business operations, customer acquisition and financial performance.
- Risks Relating to the Business: The Company may incur significant customer acquisition, marketing and distribution costs in connection with its D2C operations, which may adversely affect the company profitability and margins.
- Risks Relating to the Business: The Company's D2C operations expose it to risks relating to logistics, fulfillment, scalability and competition, which may adversely affect its business and profitability.
- Risks Relating to the Business: The company's manufacturing units are subject to periodic inspections and audits by regulatory authorities and its customers. Any manufacturing or quality control problems may subject the company to regulatory action, damage its reputation and have an adverse effect on the company's business, results of operations, financial condition and cash flows.
- Risks Relating to the Business: Certain of the company's third-party manufacturing customers may operates in the same product categories as its branded products business, which could give rise to potential conflicts of interest and may adversely affect the company's business.
- Risks Relating to the Business: The company operations are labour intensive, and its may be subject to strikes, work stoppages or increased wage demands by the company's employees, which could adversely affect its business, results of operations and financial condition.
- Risks Relating to the Business: The company operations are primarily focused on the domestic market, and any adverse developments in India could materially affect its business.
- Risks Relating to the Business: The Company has experienced delays in obtaining certain statutory environmental approvals, and any future non-compliance with applicable environmental laws may expose it to regulatory action and penalties.
- Risks Relating to the Business: Under-utilization of the company's manufacturing capacities may have an adverse effect on its business, future prospects and future financial performance. Moreover, information relating to capacity utilization of the company's production facility included in this Red Herring Prospectus is based on certain assumptions and has been subjected to rounding off and future production and capacity utilization may vary.
- Risks Relating to the Business: The Company is reliant on the demand from the Ayurvedic industry for a significant portion of its revenue. Any downturn in the Ayurvedic industry or an inability to increase or effectively manage its sales could have an adverse impact on the Company's business and results of operations.
- Risks Relating to the Business: The company's manufacturing operations are subject to risks, including equipment failures, accidents, and natural disasters, which could disrupt production.
- Risks Relating to the Business: The company has certain contingent liabilities and its financial condition and profitability may be adversely affected if any of those contingent liabilities materialize.
- Risks Relating to the Business: The Company in involved certain tax proceedings which are pending before the appellate tribunal. Any adverse decision in such proceedings may render the company liable to liabilities/penalties and may adversely affect its business and results of operations.
- Risks Relating to the Business: The company's ability to sustain growth and remain competitive depends on its ability to effectively manage the company operating costs.
- Risks Relating to the Business: The Ayurvedic industry is intensely competitive and the company's inability to compete effectively may adversely affect its business, results of operations, financial condition and cash flows.
- Risks Relating to the Business: The company has incurred indebtedness and an inability to comply with repayment and other covenants in its financing agreements could adversely affect the company's business and financial condition.
- Risks Relating to the Business: Certain of the company's Promoters have provided personal guarantees for certain borrowings obtained by the Company. Any failures or default by the Company to repay such loans could trigger repayment obligations on its Promoters which may impact their ability to effectively service their obligations and thereby, adversely impact the company's business and operations.
- Risks Relating to the Business: The regulatory framework governing sourcing, testing and quality requirements for raw materials used in the company's products may become more stringent, which could increase its compliance costs and adversely affect the company operations.
- Risks Relating to the Business: The company is dependent on third party transportation and logistics service providers. Any increase in the charges of these entities could adversely affect its business, results of operations and financial condition.
- Risks Relating to the Business: The Company has acquired rights, title, and interest in certain trademarks pursuant to duly executed assignment deeds, uncertainty in approval of post-registration changes for assigned trademarks may adversely affect its rights and operations.
- Risks Relating to the Business: The company interactions with healthcare professionals are subject to strict ethical standards and regulatory requirements. Any actual or alleged failures to comply may result in regulatory action, monetary penalties, reputational harm, and an adverse impact on the company's business.
- Risks Relating to the Business: Changes in taxation or import and export duties and documentation norms may adversely affect the company's cost structures and timelines for entering international markets.
- Risks Relating to the Business: The company's insurance coverage may not be sufficient or adequate to protect it against all material hazards, which may adversely affect the company's business, results of operations, financial condition and cash flows.
- Risks Relating to the Business: The company operations are subject to high working capital requirements. The company's inability to maintain an optimal level of working capital required for its business may impact the company operations adversely.
- Risks Relating to the Business: As the company continue to grow, its may not be able to effectively manage the company's growth and the increased complexity of its business, which could negatively impact the company and financial performance.
- Risks Relating to the Business: The company has in the past entered into related party transactions and may continue to do so in the future.
- Risks Relating to the Business: Any variation in the utilization of the Net Proceeds as disclosed in this Red Herring Prospectus shall be subject to certain compliance requirements, including prior approval of the shareholders of the Company.
- Risks Relating to the Business: The company is required to obtain, renew or maintain certain material statutory and regulatory permits and approvals required to operates its business, and if the company fails to do so in a timely manner or at all, its may be unable to operates the company's business and its results of operations may be adversely affected.
- Risks Relating to the Business: The company is exposed to counterparty credit risk and any delay in receiving payments or non-receipt of payments may adversely impact its results of operations.
- Risks Relating to the Business: If the company fails to maintain an effective system of internal controls, its may not be able to successfully manage, or accurately report, the company's financial risks.
- Risks Relating to the Business: Major fraud, system failures, theft, employee negligence or similar incidents could adversely impact the Company's business.
- Risks Relating to the Business: The company may requires additional capital to support the growth of its business, which may not be available on terms favourable to the company or at all and may impose certain restrictive covenants that limit its operations or the company's ability to pay dividends, or in the case of an issuance of securities, dilute its shareholders.
- Risks Relating to the Business: The company has issued Equity shares in the last one year from the date of this Red Herring Prospectus, which could have been issued at a price lower than the Issue price.
- Risks Relating to the Business: The company relies on certain key operating metrics and non-GAAP measures to evaluate the performance of its business, and real or perceived inaccuracies in such metrics may harm the company's reputation and negatively affect its business.
- Risks Relating to the Business: The company's Key Managerial Personnel does not have prior experience in managing the affairs of a listed company, which may impact its ability to comply with regulatory requirements.
- Risks Relating to the Business: Certain of its Key Managerial Personnel ("KMP") have been associated with the Company for less than a year, which may pose challenges in terms of understanding its business operations and industry.
- Risks Relating to the Business: The company's Directors and key managerial personnel have interests in the Company in addition to their remuneration and reimbursement of expenses.
- Risks Relating to the Business: The company's Promoters and members of the Promoter Group will continue jointly to retain majority control over the Company even after the Issue which will allow them to determine the outcome of matters submitted to shareholders for approval.
- Risks Relating to the Business: The Equity Shares of face value of Rs. 10 each have never been publicly traded, and, after the Issue, the Equity Shares of face value of Rs.10 each may experience price and volume fluctuations, and an active trading market for the Equity Shares of face value of Rs.10 each may not develop.
- Risks Relating to the Business: The company's ability to pay any dividends will depends upon future earnings, financial condition, cash flows and working capital requirements.
- Risks Relating to the Business: Certain sections of this Red Herring Prospectus contain information from the Infomerics Report which has been commissioned and paid for by the company and any reliance on such information for making an investment decision in this offering is subject to inherent risks.
- Risks Relating to the Business: The Issue price of the company's Equity Shares may not be indicative of the market price of its Equity Shares after the Issue and the market price of the company's Equity Shares may decline below the Issue price and you may not be able to sell your Equity Shares at or above the Issue Price.
- Risks Relating to the Business: There is no guarantee that the Equity Shares issued pursuant to the Issue will be listed on exchange in a timely manner or at all.
- Risks Relating to the Business: The requirements of being a public listed company may strain its resources and impose additional requirements.
